For instance, several authors have reported unchanged SV2A levels in the middle frontal gyrus (Metaxas et al., 2019), the hippocampus, entorhinal cortex, caudate nucleus, and occipital cortex (Sze et al., 2000) in post-mortem samples from AD patients. This evidence concerns the gene SV2A and Alzheimer disease.